US11725008B2

Ethanediamine-heterocycle derivatives as inhibitors of protein arginine …

University of Texas System

Abstract

The present invention relates to ethanediamine-heterocycle compounds that are able to act as inhibitors of PRMTs (protein arginine methyltransferases) for treating cancer and other diseases mediated by PRMTs.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Maria Emilia Di Francesco
Priority date: March 01, 2018
Filing date: May 04, 2021
Grant date: August 15, 2023
Publication date: August 15, 2023
Language: en
PDF source: https://patentimages.storage.googleapis.com/18/cb/2d/83514d7e73cd76/US11725008.pdf
Metadata fetched: August 29, 2026 00:31